Free Trial
NASDAQ:CDTTW

Conduit Pharmaceuticals (CDTTW) Stock Price, News & Analysis

$0.08
+0.02 (+32.26%)
(As of 05/21/2024 ET)
Today's Range
$0.08
$0.09
50-Day Range
$0.04
$0.10
52-Week Range
$0.01
$0.18
Volume
1,109 shs
Average Volume
9,262 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

CDTTW Stock Price History

CDTTW Stock News Headlines

Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?
See More Headlines
Receive CDTTW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CDTTW
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. David Joszef Tapolczay (Age 65)
    CEO & Director
    Comp: $419.8k
  • Mr. Adam Sragovicz (Age 54)
    Chief Financial Officer
    Comp: $116.67k
  • Dr. Joanne M. Holland (Age 49)
    Chief Scientific Officer

CDTTW Stock Analysis - Frequently Asked Questions

How have CDTTW shares performed in 2024?

Conduit Pharmaceuticals' stock was trading at $0.0693 on January 1st, 2024. Since then, CDTTW shares have increased by 18.3% and is now trading at $0.0820.
View the best growth stocks for 2024 here
.

How do I buy shares of Conduit Pharmaceuticals?

Shares of CDTTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CDTTW) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners